Won Jin Ho (Won J Ho)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 33

Top Topics

Locally Advanced

Natural Killer Cells

Endoscopic Submucosal Dissection

Top Venues

Cancer immunology research

Cancer research

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Zoe X Malchiodi, Robert K Suter, Atul Deshpande, Ivana Peran, Brent T Harris, Anju Duttargi, Min-Ju Chien, Samika Hariharan, Lucia Wetherill, Sandra A Jablonski, Won Jin Ho, Elana J Fertig, Louis M Weiner
Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironment. bioRxiv : the preprint server for biology (2024)
Eloïse M Grasset, Atul Deshpande, Jae W Lee, Yeonju Cho, Sarah M Shin, Erin M Coyne, Alexei Hernandez, Xuan Yuan, Zhehao Zhang, Ashley Cimino-Mathews, Andrew J Ewald, Won Jin Ho
Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells. Oncogene (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multi-omics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research (2024)
Zoe X Malchiodi, Robert K Suter, Atul Deshpande, Ivana Peran, Brent T Harris, Anju Duttargi, Min-Ju Chien, Samika Hariharan, Lucia Wetherill, Sandra A Jablonski, Won Jin Ho, Elana J Fertig, Louis M Weiner
Natural killer cells associate with epithelial cells in the pancreatic ductal adenocarcinoma tumor microenvironment. bioRxiv : the preprint server for biology (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research 84 (16) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Jiang Chen, Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Ze-Long Liu, Sarah M Shin, Aya Matsui, Alexei Hernandez, Zhangya Pu, Stefan Halvorsen, Pin-Ji Lei, Meenal Datta, Lingling Zhu, Zhi-Ping Ruan, Lei Shi, Daniel Staiculescu, Koetsu Inoue, Lance L Munn, Dai Fukumura, Peigen Huang, Slim Sassi, Nabeel El-Bardeesy, Won Jin Ho, Rakesh K Jain, Dan G Duda
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy. Cancer immunology research (2024)
Shuming Zhang, Atul Deshpande, Babita K Verma, Hanwen Wang, Haoyang Mi, Long Yuan, Won Jin Ho, Elizabeth D Thompson, Qingfeng Zhu, Robert A Anders, Mark Yarchoan, Luciane Tsukamoto Kagohara, Elana J Fertig, Aleksander S Popel
Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery. Cancer research 84 (16) (2024)
Mari Nakazawa, Mike Fang, Tyrus Vong, Jane Zorzi, Paige Griffith, Robert A Anders, Kiyoko Oshima, Amy K Kim, Jacqueline Laurin, Kelly J Lafaro, Christopher R Shubert, William R Burns, Jin He, Richard Andrew Burkhart, Benjamin Philosophe, Jeffrey Meyer, Robert P Liddell, Christos S Georgiades, Kelvin Hong, Won Jin Ho, Nilofer S Azad, Alexandra T Strauss, Mark Yarchoan
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC. Cancer research communications 4 (8) (2024)
Daniel J Zabransky, Mark Yarchoan, Won Jin Ho
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy. Hepatology (Baltimore, Md.) 79 (4) (2023)
Daniel J Zabransky, Mark Yarchoan, Won Jin Ho
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy. Hepatology (Baltimore, Md.) (2023)
Daniel J Zabransky, Mark Yarchoan, Won Jin Ho
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy. Hepatology (Baltimore, Md.) 79 (4) (2023)
Stephanie L Alden, Mir Lim, Chester Kao, Daniel H Shu, Amit G Singal, Anne M Noonan, Paige Griffith, Nilofer S Azad, Won Jin Ho, Ihab R Kamel, Mark Yarchoan, David Hsiehchen
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma. Cancer research communications 3 (7) (2023)
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Nicole D Fleming, Michael S Lee, Brandon G Smaglo, Y Nancy You, Matthew M Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind N Dasari, Sarah M Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maheshbhai Maru, Edmund S Kopetz, Michael James Overman
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Daniel J Zabransky, Mark Yarchoan, Won Jin Ho
Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy. Hepatology (Baltimore, Md.) 79 (4) (2023)
Daniel H Shu, Won Jin Ho, Luciane Tsukamoto Kagohara, Alexander A Girgis, Sarah M Shin, Ludmila V Danilova, Jae W Lee, Dimitrios N Sidiropoulos, Sarah Mitchell, Kabeer Munjal, Kathryn Howe, Kayla J Bendinelli, Hanfei Qi, Guanglan Mo, Janelle Montagne, James M Leatherman, Tamara Y Lopez-Vidal, Qingfeng Zhu, Amanda L Huff, Xuan Yuan, Alexei Hernandez, Erin M Coyne, Neeha Zaidi, Daniel J Zabransky, Logan L Engle, Aleksandra Ogurtsova, Nilofer S Azad, Daniel Laheru, Jennifer N Durham, Hao Wang, Robert Anders, Elizabeth D Thompson, Elana J Fertig, Mark Yarchoan
Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade. bioRxiv : the preprint server for biology (2023)
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Nicole D Fleming, Michael S Lee, Brandon G Smaglo, Y Nancy You, Matthew M Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind N Dasari, Sarah M Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen Maheshbhai Maru, Edmund S Kopetz, Michael James Overman
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Won Jin Ho, Ludmila Danilova, Su Jin Lim, Rohan Verma, Stephanie Xavier, James M Leatherman, Marcelo B Sztein, Elana J Fertig, Hao Wang, Elizabeth Jaffee, Mark Yarchoan
Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma. Journal for immunotherapy of cancer 8 (1) (2021)
Won Jin Ho, Gaurav Sharma, Qingfeng Zhu, Genevieve Stein-O'Brien, Jennifer Durham, Robert Anders, Aleksandra Popovic, Guanglan Mo, Ihab Kamel, Matthew Weiss, Elizabeth Jaffee, Elana J Fertig, Mark Yarchoan
Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy. Journal for immunotherapy of cancer 8 (2) (2021)